Interventional Spine Market Size & Share 2024 - 2032

Interventional Spine Market Size

Interventional Spine Market size was valued at around USD 13.8 billion in 2023 and is anticipated to register a CAGR of 4.8% between 2024 and 2032. Factors such as rising prevalence of spinal diseases, consistent technological advancements, and increasing demand for minimally invasive procedures are propelling the market growth.

The growing prevalence of spinal diseases has led to an increased demand for interventional spine procedures globally. Sedentary lifestyles, obesity, insufficient physical activity, trauma injuries, genetic and congenital factors, and an increasing aging population have been linked to several serious spinal disorders, including a surging incidence of spinal deformities, scoliosis, herniated discs, lumbar stenosis, and other spinal disorders.
 

Further, as per the statistics reported by World Spine Care organization, there are more patients worldwide affected by spinal pain than by HIV, diabetes, malaria, stroke, Alzheimer's disease, and breast cancer altogether. Additionally, the increasing demand for minimally invasive procedures is rising globally due to various advantages, like minimized surgical tissue trauma compared with an open surgical procedure, improved patient outcomes, and reduced hospital stays among others. Therefore, the rising prevalence of spinal diseases and growing demand for minimally invasive procedures will fuel the interventional spine market expansion.
 

Interventional spine refers to a specialized field of medicine focused on the diagnosis and treatment of spinal disorders and related pain conditions using minimally invasive procedures. Interventional spine procedures typically involve the use of image-guided techniques, such as fluoroscopy or ultrasound, to precisely target affected areas of the spine with minimal tissue disruption.
 

Interventional Spine Market Trends

The consistent technological advancements in interventional spine by incorporating the innovative technologies in the devices has resulted in their increased demand globally. Utilization of favourable technologies such as bone grafting materials, cervical plates, and balloon kyphoplasty has led to the segment progress.
 

• Ongoing research and development efforts have resulted in innovative spinal fusion procedures, including thoracic and lumbar fusion devices. For instance, these procedures utilize bone grafting materials, that includes bone graft substitutes such as bone marrow aspirate, mesenchymal stem cells or allograft in combination with synthetic grafts or ceramics. These materials reduce the need for traditional autografts and promote bone growth and fusion, contributing to the overall success and increased demand for spinal fusion procedures worldwide.
   
• Further, the effectiveness of cervical fusion devices is being enhanced through the incorporation of dynamization features, such as movable screws within cervical plates. These dynamic elements promote bone growth and fusion in the cervical spine. This dynamization feature optimizes the stability of the implant while promoting a more natural healing process, ultimately improving the success rate of cervical fusion procedures and attracts the attention of surgeons and healthcare professionals.
   

Interventional Spine Market Analysis

Based on product, the market is segmented into thoracic fusion and lumbar fusion devices, cervical fusion devices, vertebral compression fracture treatment devices, spine biologics, spinal decompression devices, non-fusion devices, and spine bone stimulators. The thoracic fusion and lumbar fusion devices segment held leading revenue share in 2023 and is anticipated to reach USD 8.1 billion by 2032.
 

• The rising demand for motion-preserving solutions in spinal surgery, such as artificial disc replacement (ADR), reflects a growing trend towards preserving natural spinal motion and biomechanics. Fusion devices continue to play a crucial role, particularly in cases of severe instability or deformity where motion preservation may not be feasible.
   
• Additionally, patients with debilitating spinal conditions often seek surgical interventions to improve their quality of life, alleviate pain, and restore functional mobility. Fusion procedures, when indicated, offer the potential for long-term relief of symptoms, and improved spinal stability, thereby, driving patient demand for these devices.

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the interventional spine market is segmented into spinal fusion and fixation, vertebral compression fracture treatment, motion preservation/non-fusion, and spinal decompression. The spinal fusion and fixation segment held majority revenue share in 2023 and is anticipated to reach USD 12.8 billion by 2032.
 

• The aging population is often associated with degenerative spinal conditions promoting the onset of degenerative spinal ailments like spinal stenosis and degenerative spondylolisthesis, necessitating spinal fusion and fixation procedures.
   
• Additionally, increased investment in healthcare infrastructure leads to the expansion of healthcare facilities, thus enhancing the access to specialized medical care, such as spinal surgeries, for a larger portion of the population. Factors including continuous rise in target population and as more individuals have access to healthcare services, there is a corresponding increase in the number of patients seeking treatment for spinal conditions, thereby driving the demand for spinal fusion and fixation procedures.
   

Based on surgery type segmentation, the interventional spine market is categorized into open surgery and minimally invasive surgery. The minimally invasive surgery segment is anticipated to record higher growth with a CAGR of 5.5% over the forecast period.
 

• The proliferation of information available to individuals or patients undergoing spinal surgeries through various sources including awareness campaigns, internet and social media platforms has empowered patients to take a more proactive role in their healthcare decisions. With increased awareness, and access to information, patients are actively seeking out minimally invasive treatment options, further driving demand for these innovative and patient-centric solutions.
   
• Additionally, while the initial costs of MIS equipment and training may be higher, the overall cost-effectiveness of MIS becomes evident when considering factors such as shorter hospital stays, reduced postoperative care requirements, and faster patient recovery. As healthcare systems and payers increasingly prioritize value-based care and cost containment, the cost-effectiveness of MIS becomes a significant driver for demand for such procedures.
   

Based on end-use segmentation, the interventional spine market is categorized into hospitals, specialty clinics, ambulatory surgical centers, and other end-users. The hospital segment accounted for majority revenue share and was valued at around USD 7.6 billion revenue in 2023.
 

• Hospitals attract and retain specialized medical professionals including orthopedic spine surgeons, interventional spine specialists, neurosurgeons specializing in spine surgery, and pain management physicians who are proficient in minimally invasive spine interventions and adept at handling associated devices.
   
• By assembling a skilled team of professionals, hospitals ensure the delivery of high-quality care and optimal outcomes for patients undergoing interventional spine procedures. This strategic investment in specialized expertise positions hospitals as the primary location for interventional spine procedures.
   
• Moreover, hospitals ensure a safe environment for incorporating advanced procedures and devices related to interventional spine by meeting the stringent regulatory compliance and accreditation standards. Consequently, hospitals become the preferred choice for patients seeking interventional spine treatments.

North America interventional spine market accounted for USD 8 billion revenue in 2023 and is predicted to witness substantial market growth.
 

• North America has a significant presence of extensive research institutions, medical schools, and professional organizations that underscores the region's commitment to advancing in the field of interventional spine. These entities drive innovation by fostering the development of advanced technologies, and treatments models. This concerted effort fuels the growth of the regional market, hence driving advancements and shaping the future of spinal healthcare.
   
• Additionally, many interventional spine procedures are covered by health insurance plans in the region, making them more accessible and affordable for patients. Insurance coverage encourages patients to seek out treatment for spinal conditions, contributing to the growth of the market in the region.
   

Interventional Spine Market Share

The interventional spine industry is competitive in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products with improved efficiency and cost-effectiveness is among a key market strategy for interventional spine manufacturers. Some of the leading industry players including Alphatec Holdings, Inc, B. Braun Melsungen AG, Boston Scientific Corporation, ChoiceSpine LLC, and DePuy Synthes among others have a substantial presence in the market.
 

Interventional Spine Market Companies

Some of the eminent market participants operating in the interventional spine industry include:

• Alphatec Holdings, Inc.
• B. Braun Melsungen AG
• Boston Scientific Corporation
• ChoiceSpine LLC
• DePuy Synthes
• Globus Medical, Inc.
• Integra LifeSciences Corporation
• Medtronic plc
• Nuvasive, Inc.
• Orthofix Medical Inc.
• RTI Surgical
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
   

Interventional Spine Industry News:

• In February 2024, Boston Scientific received FDA approval for its Wavewriter Alpha Spinal Cord Stimulator (SCS) Systems for the treatment of non-surgical back pain. This approval expands the indication for use of the SCS systems to include chronic back pain without prior back surgery. The multipurpose use of the device may attract the attention of healthcare professionals and may achieve better revenue results for the company.
   
• In September 2022, Stryker Corporation received FDA clearance for its OptaBlate Bone Tumor Ablation System, which provides a minimally invasive approach to pain relief for patients suffering from debilitating bone tumors. This approval expanded the company’s interventional spine portfolio and may enable a greater market positioning to the company.
   

Interventional spine market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Thoracic fusion and lumbar fusion devices
  • Posterior thoracic fusion and lumbar fusion devices
  • Interbody thoracic fusion and lumbar fusion devices
  • Anterior thoracic fusion and lumbar fusion devices
• Cervical fusion devices
  • Anterior cervical fusion devices
  • Posterior cervical fusion devices
• Vertebral compression fracture treatment devices
  • Balloon kyphoplasty devices
  • Vertebroplasty devices
• Spine biologics
  • Demineralized bone matrix
  • Bone morphogenetic proteins
  • Bone substitutes
  • Machined bones
  • Cell-based matrices
  • Allograft bone
• Spinal decompression devices
  • Discectomy
  • Laminoplasty, laminectomy, and laminotomy
  • Foraminotomy & foraminectomy
  • Facetectomy
  • Corpectomy
• Non-fusion devices
  • Dynamic stabilization
  • Artificial discs replacement
    • Artificial cervical disc
    • Artificial lumbar disc
  • Annulus repair devices
  • Nuclear disc prostheses
• Spine bone stimulators
  • Noninvasive spine bone stimulators
    • Pulsed electromagnetic field devices
    • Capacitive coupling (CC) devices
    • Combined (electro) magnetic field (CMF) devices
  • Invasive spine bone stimulators

Market, By Application

• Spinal fusion and fixation
• Vertebral compression fracture treatment
• Motion preservation/non-fusion
• Spinal decompression

Market, By Surgery Type

• Open surgeries
• Minimally invasive surgeries

Market, By End-use

• Hospitals
• Specialty clinics
• Ambulatory surgical centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa